glp-1 in brain programs the neurovascular landscape: Cell Metabolism Glucagon-Like Peptide 1: An Introduction

They have developed an antibody (a more complex molecule than a peptide) that antagonizes GIP

In September 2023 , Novo Nordisk informed Australias Therapeutic Goods Administration and the Ozempic Medicine Shortage Action Group that supply constraints would persist into 2024

D.CalderwoodD.GillespieA.CryanJ

### US Regional Pricing Variations | Region | Compounded Monthly Cost | Telehealth Consultation | Notes | |--------|------------------------|------------------------|-------| | Northeast (NY, NJ, MA, CT) | $350-650 | $150-250 | Higher pharmacy costs | | Southeast (FL, GA, TX, NC) | $250-500 | $100-200 | More competitive pricing | | Midwest (IL, OH, MI, MN) | $280-520 | $100-175 | Moderate pricing | | West Coast (CA, WA, OR) | $300-600 | $150-250 | Premium market | | Mountain West (CO, AZ, UT) | $260-480 | $100-175 | Growing availability | ### How US Patients Access Retatrutide 1

Although GLP-1RAs have been extensively studied for therapeutic applications in neuropsychiatric disorders, it is yet to be determined whether tirzepatide shares similar neuroprotective properties

Additionally, the JPML was asked to add more injuries (i.e., blood clots and NAION) to this group lawsuit filing